489
delivery, oxytocin requirements were substantially lower in the mifepristone group (1.25 [1’59] IU vs 3.18 [3’17] IU; p < 001). 25 women
with unfavourable cervical conditions
on
day
4 needed
cervical maturation with vaginal prostaglandins. 17 were receiving
placebo (total of 32 tablets) and 8 mifepristone (total of 10 tablets; p
delivery, oxytocin requirements were substantially lower in the mifepristone group (1.25 [1’59] IU vs 3.18 [3’17] IU; p < 001). 25 women
with unfavourable cervical conditions
on
day
4 needed
cervical maturation with vaginal prostaglandins. 17 were receiving
placebo (total of 32 tablets) and 8 mifepristone (total of 10 tablets; p
